Q2 2025 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2025-08-14 · accession 0001172661-25-003253
$1.09B
Reported value
72
Positions
2025-06-30
Period end
The Brief · Integral Health Asset Management, LLC · Q2 2025
AI · grounded in 13F
Integral Health Asset Management, LLC established a new position in INSM valued at $161.02M. The fund also initiated new stakes in BSX for $59.08M and CYTK for $49.56M. Additional new positions include THC at $48.4M and EHC at $39.24M. Total assets under management stand at $1.09B across 71 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $161.0M | 14.7% | 1,600,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $59.1M | 5.41% | 550,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $48.4M | 4.43% | 275,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $39.2M | 3.59% | 320,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $36.5M | 3.34% | 2,700,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $33.0M | 3.02% | 1,000,000 | Common | SOLE |
| 10950A106 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $29.5M | 2.70% | 1,250,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $27.1M | 2.48% | 1,150,000 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $26.9M | 2.47% | 150,000 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $26.3M | 2.40% | 50,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $24.2M | 2.22% | 200,000 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $23.5M | 2.15% | 140,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $23.3M | 2.14% | 60,000 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $22.8M | 2.08% | 400,000 | Common | SOLE |
| 358029106 | FMS | FRESENIUS MEDICAL CARE AG | $21.4M | 1.96% | 750,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $19.5M | 1.78% | 25,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $18.9M | 1.73% | 150,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $18.8M | 1.72% | 1,350,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $17.9M | 1.64% | 55,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $17.5M | 1.60% | 200,000 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $17.4M | 1.60% | 115,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $17.4M | 1.60% | 200,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $17.2M | 1.58% | 250,000 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $17.0M | 1.55% | 700,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $16.5M | 1.51% | 500,000 | CALL | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $15.6M | 1.43% | 200,000 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $14.8M | 1.36% | 200,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $14.0M | 1.28% | 200,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $13.1M | 1.20% | 1,000,000 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $12.7M | 1.16% | 1,250,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $12.0M | 1.09% | 325,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $10.3M | 0.94% | 1,050,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $10.3M | 0.94% | 40,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $9.4M | 0.86% | 200,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $9.1M | 0.83% | 70,000 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY IN | $9.1M | 0.83% | 400,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $8.5M | 0.78% | 500,000 | Common | SOLE |
| 436440101 | HO1 | HOLOGIC INC | $8.1M | 0.75% | 125,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $8.1M | 0.74% | 200,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $8.0M | 0.73% | 1,800,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $7.6M | 0.69% | 120,000 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $7.6M | 0.69% | 250,000 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $7.4M | 0.68% | 40,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $7.3M | 0.67% | 10,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $6.8M | 0.62% | 600,000 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $6.2M | 0.56% | 40,000 | Common | SOLE |
| 00846U101 | A | AGILENT TECHNOLOGIES INC | $5.9M | 0.54% | 50,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $5.7M | 0.53% | 700,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $5.7M | 0.52% | 60,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $5.6M | 0.51% | 400,000 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $5.3M | 0.49% | 1,050,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $5.3M | 0.49% | 100,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $5.3M | 0.49% | 200,000 | CALL | SOLE |
| 941848103 | WAT | WATERS CORP | $5.2M | 0.48% | 15,000 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $5.2M | 0.47% | 50,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $5.0M | 0.46% | 350,000 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $5.0M | 0.46% | 70,000 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $4.9M | 0.45% | 100,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $4.2M | 0.39% | 1,400,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $4.2M | 0.39% | 300,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $4.1M | 0.37% | 1,500,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $3.6M | 0.33% | 100,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $3.5M | 0.32% | 100,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $3.5M | 0.32% | 310,000 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $3.3M | 0.30% | 590,000 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $3.3M | 0.30% | 150,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $2.9M | 0.26% | 100,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $2.6M | 0.24% | 700,000 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $2.4M | 0.22% | 300,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $2.1M | 0.20% | 100,000 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $961,920 | 0.09% | 167,000 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $880,000 | 0.08% | 400,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.